BUILDS MARBLES: Biorepository Upkeep and Infrastructure for Longitudinal Data Sharing for MARBLES

建造弹珠:弹珠纵向数据共享的生物储存库维护和基础设施

基本信息

  • 批准号:
    10202600
  • 负责人:
  • 金额:
    $ 36.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-30 至 2022-12-25
  • 项目状态:
    已结题

项目摘要

Abstract The MARBLES (Markers of Autism Risk in Babies: Learning Early Signs) Study was launched in 2006 by the UC Davis MIND Institute and Center for Children's Environmental Health as the first epidemiologic cohort of younger siblings of children with autism spectrum disorders (ASD) to begin follow-up during (and before) the prenatal period when ASD and other neurodevelopmental outcomes are likely to originate.1-7 In contrast to population-based cohorts, which require very large sample sizes given a relatively low prevalence of ASD (currently 1 in 68)8 and typically are not able to conduct gold standard diagnosis of ASD, the enriched risk design takes advantage of participants at exceptionally high risk for developing ASD and other neurodevelopmental outcomes, achieving tremendous efficiencies. Previous cohorts of high-risk younger siblings recruited postnatally have not addressed non-inherited and potentially modifiable etiologic factors.9 Early enrollment provides an opportunity to examine a broad array of environmental exposures and their mechanisms, while simultaneously allowing thorough search for early biologic markers.10 Given increasing prevalence of ASD,8,11 it is more critical now than ever to invest in studies identifying emerging environmental factors responsible for increasing risk of these neurodevelopmental disorders and the mechanisms underlying their etiology, which are currently not well-understood. This project addresses both gaps by maintaining and enhancing the resource infrastructure of the MARBLES enriched-risk cohort. Retention of this cohort with deep evaluation of risk factors, mechanistic markers, and outcomes will be critical to evaluation and early identification of newly emerging etiologic factors for ASD in a susceptible population, serving as a canary in a coal-mine for identifying exposures that influence neurodevelopment. Our cohort's data and specimens will permit analyses of new questions on exposures in relation to well-defined clinical neurodevelopmental outcomes, and our rich characterization of mechanistic biomarkers could identify pathways and signatures of susceptibility involved. We propose to continue to enroll and follow-up participants of one of the only enriched-risk ASD U.S. cohorts with prospectively collected pregnancy data and biosamples that is currently in no cost extension (NCE). In addition, we propose to further develop and maintain our repository infrastructure for the expansive data and sample repositories in order to expand collaborative sharing and facilitate investigation of newly-emerging environmental exposures and molecular mechanistic markers in relation to risk and presentation of ASD and other adverse neurodevelopmental conditions. Finally, we plan to validate and reliability test environmental exposure questions and measures for use in future studies. Completion of these aims will assist collaborative sharing of our vast collection of data and biosamples to facilitate investigation of newly-emerging environmental exposures and molecular mechanistic markers in relation to risk and presentation of ASD and other adverse neurodevelopmental conditions.
摘要 MARBLES(婴儿自闭症风险标记:学习早期迹象)研究于2006年启动, 加州大学戴维斯分校心理研究所和儿童环境健康中心作为第一个流行病学队列, 自闭症谱系障碍(ASD)儿童的弟弟妹妹,开始随访期间(和之前), 产前阶段,ASD和其他神经发育结果可能起源。 基于人群的队列,由于ASD患病率相对较低,因此需要非常大的样本量 (目前为1/68)8,通常无法进行ASD的金标准诊断, 设计利用参与者在发展ASD和其他 神经发育的结果,实现巨大的效率。高风险年轻人的既往队列 出生后招募的兄弟姐妹没有解决非遗传性和潜在的可改变的病因因素。 早期登记提供了一个机会,检查广泛的环境暴露及其 机制,同时允许彻底搜索早期生物标志物。 鉴于ASD的患病率日益增加,现在比以往任何时候都更重要的是投资于研究,以确定 新出现的环境因素导致这些神经发育障碍的风险增加, 其病因学的潜在机制,目前还没有很好地理解。该项目同时解决了这两个问题 通过维持和加强MARBLES富集风险队列的资源基础设施,缩小差距。 保留该队列并对风险因素、机制标志物和结局进行深入评价至关重要 评估和早期鉴定易感人群中ASD的新出现的病因因素, 就像煤矿里的金丝雀,用来识别影响神经发育的暴露。我们这群人 数据和样本将允许分析与明确定义的临床 神经发育结果,我们丰富的机械生物标志物的特征可以识别 相关的易感性途径和特征。我们建议继续招募和随访参与者 美国唯一一个具有前瞻性收集的妊娠数据和生物样本的高风险ASD队列之一 这是目前在无成本扩展(NCE)。此外,我们建议进一步发展和维持我们的 用于扩展数据和样本存储库的存储库基础设施, 分享和促进对新出现的环境暴露和分子机制的调查 与ASD和其他不良神经发育状况的风险和表现相关的标志物。最后, 我们计划验证和可靠性测试环境暴露问题和措施,以供将来使用 问题研究这些目标的完成将有助于我们大量收集的数据和生物样本的合作共享 促进对新出现的环境暴露和分子机制标志物的研究, 与ASD和其他不良神经发育状况的风险和表现的关系。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
COVID-19 Pandemic Experiences and Symptoms of Pandemic-Associated Traumatic Stress Among Mothers in the US.
美国母亲之间大流行相关的创伤应激的大流行经历和症状。
  • DOI:
    10.1001/jamanetworkopen.2022.47330
  • 发表时间:
    2022-12-01
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Bastain, Theresa M.;Knapp, Emily A.;Law, Andrew;Algermissen, Molly;Avalos, Lyndsay A.;Birnhak, Zoe;Blackwell, Courtney;Breton, Carrie, V;Duarte, Cristiane;Frazier, Jean;Ganiban, Jody;Greenwood, Paige;Herbstman, Julie;Hernandez-Castro, Ixel;Hofheimer, Julie;Karagas, Margaret R.;Lewis, Johnnye;Pagliaccio, David;Ramphal, Bruce;Saxbe, Darby;Schmidt, Rebecca;Velez-Vega, Carmen;Tang, Xiaodan;Hamra, Ghassan B.;Margolis, Amy
  • 通讯作者:
    Margolis, Amy
Gestational Vitamin D and Autism Spectrum Disorder.
妊娠维生素 D 和自闭症谱系障碍。
  • DOI:
    10.1016/j.biopsych.2021.09.014
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    10.6
  • 作者:
    Schmidt,RebeccaJ
  • 通讯作者:
    Schmidt,RebeccaJ
Maternal polyunsaturated fatty acids and risk for autism spectrum disorder in the MARBLES high-risk study.
  • DOI:
    10.1177/1362361319877792
  • 发表时间:
    2020-07
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Huang, Yunru;Iosif, Ana-Maria;Hansen, Robin L.;Schmidt, Rebecca J.
  • 通讯作者:
    Schmidt, Rebecca J.
Examining Prenatal Dietary Factors in Association with Child Autism-Related Traits Using a Bayesian Mixture Approach: Results from 2 United States Cohorts.
  • DOI:
    10.1016/j.cdnut.2023.101978
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Lyall, Kristen;Rando, Juliette;Wang, Siwen;Hamra, Ghassan B;Chavarro, Jorge;Weisskopf, Marc G;Croen, Lisa A;Fallin, M Daniele;Hertz-Picciotto, Irva;Volk, Heather E;Schmidt, Rebecca J;Newschaffer, Craig J
  • 通讯作者:
    Newschaffer, Craig J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deborah Hall Bennett其他文献

Deborah Hall Bennett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deborah Hall Bennett', 18)}}的其他基金

The CHARGE Study Phase II: A Multifactorial Approach to Autism Etiology
CHARGE 研究第二阶段:自闭症病因学的多因素方法
  • 批准号:
    10153782
  • 财政年份:
    2020
  • 资助金额:
    $ 36.86万
  • 项目类别:
The CHARGE Study Phase II: A Multifactorial Approach to Autism Etiology
CHARGE 研究第二阶段:自闭症病因学的多因素方法
  • 批准号:
    10343808
  • 财政年份:
    2020
  • 资助金额:
    $ 36.86万
  • 项目类别:
Revisiting ReCHARGE: ECHO Follow up on Middle Childhood and Adolescence
重温 ReCHARGE:ECHO 对童年中期和青春期的跟进
  • 批准号:
    10745252
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children
CHARGE 研究儿童的青春期前和青春期后期随访
  • 批准号:
    10240314
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children - Diversity Supplement
CHARGE 研究儿童的青春期前和青春期后期随访 - 多样性补充
  • 批准号:
    10412853
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children
CHARGE 研究儿童的青春期前和青春期后期随访
  • 批准号:
    10675376
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children
CHARGE 研究儿童的青春期前和青春期后期随访
  • 批准号:
    10470815
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children
CHARGE 研究儿童的青春期前和青春期后期随访
  • 批准号:
    10013293
  • 财政年份:
    2016
  • 资助金额:
    $ 36.86万
  • 项目类别:
Exposure Core
曝光核心
  • 批准号:
    10190947
  • 财政年份:
    2015
  • 资助金额:
    $ 36.86万
  • 项目类别:
Exposure Core
曝光核心
  • 批准号:
    10388389
  • 财政年份:
    2015
  • 资助金额:
    $ 36.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了